Shamburg News · 8-K filed Oct 6, 2026, 5:20 PM EDT

ChronoScale Director Scott Davis Resigns After Ekso Bionics Sale; Release Agreement Signed

CHRN · ChronoScale Holdings Corp

  • Leadership change
  • Material agreement
  • Materiality: medium

ChronoScale Holdings disclosed that Scott Davis, a board member and CEO of subsidiary Ekso Bionics, resigned from the Board effective October 3, 2026, following the completed sale of Ekso on September 30, 2026. On October 2, 2026, the company granted Davis 51,626 fully vested RSUs and entered into a Release Agreement providing a $709,500 lump sum cash payment, less withholdings, payable within 30 days, in exchange for a general release of claims. The release payment replaces any payment due under his November 5, 2025 Change in Control and Severance Agreement.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001493152-26-046010.

Written from the filing by Shamburg Markets. Figures are as reported by the company.